Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide ...

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

People prescribed GLP-1 agents liraglutide (Saxenda) or semaglutide for weight loss decreased their alcohol intake by almost ...

Novo Nordisk’s Wegovy (semaglutide injection) 2.4mg has demonstrated early protection against heart disease, according to new ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...

Our Bureau, Mumbai Monday, May 12, 2025, 14:45 Hrs [IST] ...

Wegovy can cause some side effects. The most common side effects of semaglutide are nausea, vomiting, and diarrhoea. Other ...

Glucagon-like peptide-1 receptor agonists improve cardiovascular outcomes and reduce mortality in patients with type 2 ...